An atypical case of Epstein-Barr virus-positive plasma cell post-transplant lymphoproliferative disorder successfully treated with adoptive cell therapy
Details
Publication Year 2021-10,Volume 195,Issue #1,Page 140-143
Journal Title
British Journal of Haematology
Publication Type
Case report
Keywords
Blood Viscosity; Clone Cells/chemistry/virology; Combined Modality Therapy; Epstein-Barr Virus Infections/*therapy; Female; *Hematopoietic Stem Cell Transplantation/adverse effects; Herpesvirus 4, Human/immunology/isolation & purification; Humans; Immunocompromised Host; Immunoglobulin M/blood; Immunosuppressive Agents/adverse effects; *Immunotherapy, Adoptive; Lymphoproliferative Disorders/etiology/*therapy/virology; Neoplastic Stem Cells/chemistry/virology; Paraproteinemias/etiology/*therapy/virology; Paraproteins/analysis; Plasma Cells/chemistry/virology; Plasmapheresis; Postoperative Complications/*therapy; Remission Induction; T-Cell Antigen Receptor Specificity; T-Lymphocytes, Cytotoxic/immunology/*transplantation; Transplantation Conditioning/adverse effects; Viremia/etiology/*therapy; Virus Activation; Young Adult
Department(s)
Haematology
PubMed ID
34180535
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-09-24 05:52:45
Last Modified: 2026-09-24 05:53:56
An error has occurred. This application may no longer respond until reloaded. Reload 🗙